Healthcare Sector – Insider-Handelsaktivität

Verfolgen Sie Insider-Käufe und -Verkäufe bei Healthcare-Aktien. Sehen Sie, welche Führungskräfte kaufen, die Netto-Inside-Aktivität und % des gehandelten Free Floats über 3,225 Unternehmen.
Die in diesem Screen bereitgestellten Informationen dienen nur zu Informationszwecken und stellen keine Finanzberatung dar. Wir befürworten keine spezifische Investition basierend auf diesen Kriterien.
Unternehmen
Daten
Abonnieren, um auf vollständige Daten zuzugreifen
Unternehmen Geschäftsfeld Marktkapitalisierung ($) # Insidern mit Nettokäufen Nettowert gekauft ($) % des Streubesitzes gekauft % der von Insidern gehaltenen Aktien
Pharmaceuticals & Medical Research Mega (1.0tn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Mega (614.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (443.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (371.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mega (345.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (313.6bn) 0 Keine Aktivität — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (298.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (247.3bn) 0 Keine Aktivität — 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (237.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (232.3bn) -1–5 -$10M–$100M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Mega (201.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (197.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (171.6bn) 0 Keine Aktivität — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (159.4bn) 1–5 $1M–$10M 0–15% 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (151.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (143.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (138.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (137.4bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Large (137.3bn) 0 Keine Aktivität — 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (127.2bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Large (111.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 Keine Aktivität — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (104.9bn) 0 Keine Aktivität — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (101.1bn) 11–20 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (92.5bn) 0 Keine Aktivität — 15–50%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (83.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (81.9bn) 0 $1M–$10M 0–15% 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Keine Aktivität — —
Healthcare Services Large (72.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (72.3bn) 1–5 $1M–$10M 0–15% 0–15%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (65.6bn) -1–5 -$10M–$100M -0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Keine Aktivität — 0–15%
US Cencora Inc (COR)
Healthcare Services Large (60.7bn) 1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (60.5bn) 0 Keine Aktivität — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (55.1bn) 1–5 $1M–$10M 0–15% —
Healthcare Services Large (52.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (51.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (51.1bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (49.4bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (46.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (45.6bn) 0 -$100M+ -0–15% 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.0bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (44.7bn) 0 Keine Aktivität — 50%+
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (43.1bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (42.7bn) -1–5 -$10M–$100M -0–15% 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (41.0bn) 0 Keine Aktivität — 0–15%
US Waters Corp (WAT)
Healthcare Services Large (40.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (39.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (39.0bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (38.4bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (38.3bn) 0 Keine Aktivität — 0–15%
US DexCom Inc (DXCM)
Healthcare Services Large (34.0bn) 0 Keine Aktivität — 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (34.0bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (33.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (32.9bn) 0 Keine Aktivität — 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (32.4bn) 0 Keine Aktivität — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.2bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 Keine Aktivität — 50%+
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (31.4bn) -1–5 -$100K–$1M -0–15% 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 Keine Aktivität — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (30.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (29.1bn) 1–5 $10M–$100M 50%+ 15–50%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (27.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (26.8bn) 0 Keine Aktivität — 15–50%
Healthcare Services Large (26.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (26.5bn) -6–10 -$100M+ -0–15% 15–50%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (26.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (25.8bn) -1–5 -$1M–$10M -0–15% 50%+
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (25.1bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (24.7bn) 0 Keine Aktivität — 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Keine Aktivität — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.3bn) 0 Keine Aktivität — 50%+
Healthcare Services Large (23.2bn) 0 Keine Aktivität — 15–50%
IE STERIS plc (STE)
Healthcare Services Large (23.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (22.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (21.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (21.7bn) -11–20 -$10M–$100M -0–15% 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (21.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (19.4bn) 0 Keine Aktivität — 50%+
Healthcare Services Large (18.8bn) 0 Keine Aktivität — 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (18.4bn) 0 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (18.2bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (18.0bn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Large (17.9bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Large (17.7bn) 1–5 $100K–$1M 0–15% 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (17.1bn) -6–10 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (16.9bn) 0 Keine Aktivität — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (16.6bn) -6–10 -$10M–$100M -0–15% 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (16.5bn) 0 Keine Aktivität — —
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Large (15.6bn) 0 Keine Aktivität — 0–15%